FIGURE

Fig. 4

ID
ZDB-FIG-230130-2
Publication
Tang Gundersen et al., 2021 - Repurposing chlorpromazine for anti-leukaemic therapy by nanoparticle encapsulation
Other Figures
All Figure Page
Back to All Figure Page
Fig. 4

Good shelf-life of nanocarriers is demonstrated by size stability and limited drug release. Freshly prepared batches of CPZ-loaded PLGA and PLGA-PEG were resuspended in PBS at pH 7.4 (A) or pH 9.5 (B,C), and kept at 4 °C in the dark and in sealed glass containers. Samples were taken at given time points and analysed for size (A,B) using DLS, and drug release (C) using HPLC as described in the Methods section. The release data represents the ratio of CPZ found in the pellet (nanoparticles) and supernatant (free form), after separation by centrifugation. The data show the average and standard deviation from three separate batches for each formulation.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int J Pharm